Our news

Our news

Charme Capital Partners Announces The Sale Of Bellco To Medtronic
  • Medtronic, founded in 1949 and among the world’s largest med-tech companies with a market cap in excess of USD 105 Billion, acquired Bellco from Charme Capital Partners and its minority co-investors (Amadeus Capital Partners and Capital Dynamics)
  • Charme Capital Partners has successfully completed the disposal of all the portfolio companies in Charme II and is now fully focused on investing Charme III

London/Milan – February 1, 2016. Charme Capital Partners, manager of the pan-European Charme Funds, today announced the execution of a definitive agreement for the sale of 100% of Bellco, the last portfolio company in Charme II, to Medtronic. Terms of the transaction were not disclosed.

Bellco, a pioneer in blood purification treatments, was acquired by Charme II in April 2012. It creates therapies and systems for the treatment of renal failure, multiple organ failure and sepsis. Bellco’s full line of dialyzers and chronic and acute dialysis machines perform dialysis for adult, pediatric and neonatal End Stage Renal Disease (ESRD) patients. For more than 40 years, Bellco has offered advanced blood purification treatments for ESRD patients with chronic and acute kidney injury. The company’s solutions are available in more than 50 countries.

Matteo di Montezemolo, Founder and Managing Partner of Charme Capital Partners said:

“During a 4-year investment cycle in Bellco, Charme has built a professional management team, supported the consolidation of key international markets including Canada, Brasil and China, and further strengthened the company in its clinical, scientific and R&D activities.

The deal executed with Medtronic represents a fitting conclusion to Charme II’s investment in Bellco. We are very proud of having created the ideal conditions to attract the interest of a global industry leader. I am convinced that this transaction represents an excellent opportunity also for Bellco.

Charme II has now successfully completed the disposal of all its portfolio companies and now, through our offices in London and Milan, is fully focused on new strategic investments at a pan-European level for Charme III.”

Andrea Traversone – Partner of Amadeus Capital Partners said:

"When we originally invested in Bellco we identified the company as pioneer in hemodialysis solutions with key treatments both for chronic dialysis and critical renal care. The acquisition of Bellco confirms the world class quality of Bellco’s technology in this field. This represents our second successful exit in Italy and co-investment with Charme Capital Partners that has been a great co-investment partner in both Bellco and Octo Telematics."

Further announcements on the development of Charme Capital Partners will be made in due course.


About Charme Capital Partners

Charme Capital Partners (www.charmecapitalpartners.com) is based in London and Milan and is the manager of the Charme Funds, founded in 2003 by Luca and Matteo di Montezemolo and backed by a unique combination of institutional LPs and prominent global industrialists. Since inception, the Charme Funds have raised approximately €1bn and invested with a pan-European approach in companies with strong growth and internationalisation prospects. In addition to Bellco, these include Poltrona Frau Group (global leader in high-end design furniture, acquired by Haworth) and Octo Telematics (world leader in insurance telematics services, acquired by Renova Group).

About Amadeus Capital Partners

Amadeus Capital Partners is a global technology investor. Since its inception in 1997, the firm has raised over $1bn for investment and backed more than 100 companies in the software, mobile, internet, cyber security and medical technology sectors. The investment team is based in India, South Africa, Sweden, UK and USA, has deep experience in technology and invests in high-growth companies from early stage to pre-IPO. Amadeus previously invested in Octo Telematics (world leader in insurance telematics services, acquired by Renova Group).

Privacy Statement

This website is operated by Charme Capital Partners SGR S.p.A. for Charme Capital Partners Limited and its affiliates (“we” or “us”). This privacy statement outlines how we use any information you may provide to us when you visit our website, and includes details of our use of cookies. If you wish to contact us in relation to our use, storage or processing of your personal data, please contact us.

If you contact us via the ‘Get In Touch’ form on our website we will hold your name and email address (as well as any other personal information you may send us, such as your phone number), which we will use to respond to your enquiry. We may also use this information to send you other business and marketing communications. If you do not wish to receive such communications you should opt out by contacting us at the email address above. As part of our processing activities we may transfer your personal information outside the EEA. While some countries outside the EEA do not offer the same level of protection for personal data as countries within the EEA, we will take all reasonable steps to ensure that your personal data is processed securely and with an adequate level of protection.

Cookies

We use cookies as set out below. Cookies are text files containing small amounts of information which are downloaded to your device when you visit a website and sent back to the originating web domain on your subsequent visits to that domain. Most web pages contain elements from multiple web domains. If you do not agree to our use of these cookies please disable them by following the instructions for your browser set out here or use the cookies’ own automated disabling tools.

We make use of analytic cookies to analyse how our visitors use our website and to monitor website performance. This allows us to provide a high quality experience by customising our offering and quickly identifying and fixing any issues that arise. Our website currently uses the following performance cookies:

Cookie name Source Purpose Further information
_utma,
_utmb,
_utmc,
_utmz
Google Analytics These cookies are used to collect information about how visitors use our website. These cookies collect information in an anonymous form, including the number of visitors to the portal, where visitors have come to the site from and the pages they visit. Persistent (except _utmc, which is a session cookie). Google Analytics provides an opt-out facility at: https://tools.google.com/dlpage/gaoptout Further information about Google’s privacy measures can be found at: https://support.google.com/analytics/ answer/6004245

We may also use your IP address and browser type to help diagnose problems with our server, to administer our products and to improve the functionality of our website. An IP address is a numeric code that identifies a user’s computer on the internet. It might also be used to gather broad demographic information. We do not use IP addresses to derive the identity of the person using the IP address.

We may make changes to this privacy statement from time to time. We therefore encourage you to review it periodically to stay informed of how we are using personal information.